Vimarsana
Biggest News Aggregation in the World

Moderna Ceo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Moderna Ceo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Moderna Ceo Today - Breaking & Trending Today

Moderna COVID-19 Vaccine to Increase Price by 400% — CEO Says It's 'Consistent with the Value' - Vimarsana News

Moderna COVID-19 Vaccine to Increase Price by 400% — CEO Says It's 'Consistent with the Value'

Moderna COVID-19 vaccine might see 400% price increase. Moderna COVID-19 vaccine price might reportedly increase by roughly 400 percent, making it cost more than $100 per dose.

Moderna Finds 'Robust Antibody Response' in Omicron-Specific Booster - Vimarsana News

Moderna Finds 'Robust Antibody Response' in Omicron-Specific Booster

Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday.

Source: webmd.com
Moderna to build Sh57bn Covid vaccine plant in Kenya - Vimarsana News

Moderna to build Sh57bn Covid vaccine plant in Kenya

American biotechnology firm Moderna will set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) vaccines, including Covid-19 shots.

Omicron-specific vaccine may be available in March, says Moderna CEO - Vimarsana News

Omicron-specific vaccine may be available in March, says Moderna CEO

"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

COVID: Global markets fall after Moderna CEO casts vaccine efficacy doubts against Omicron - Vimarsana News

COVID: Global markets fall after Moderna CEO casts vaccine efficacy doubts against Omicron

Stock markets across the globe have plunged after Moderna CEO expressed his doubts regarding the efficacy of vaccines against the Omicron COVID-19 variant.